Regeneron and Teva to bar OA patients from fasinumab trials after US study halt
Advanced osteoarthritis patients will be barred from taking part in fasinumab trials after a sufferer enrolled in a Phase IIb study developed joint disease.
Advanced osteoarthritis patients will be barred from taking part in fasinumab trials after a sufferer enrolled in a Phase IIb study developed joint disease.
A newly opened training centre in Leeds, UK will help fulfil demand for skilled workers in the drug production space, says the head of process manufacturing.
Lovelace Biomedical launched this week as a not-for-profit preclinical contract research organization (CRO) with a business model that will let it “put science first.”
Metrion has invested in new laboratories, equipment, and staff, as part of the company's continued growth strategy to form strategic alliances and add "additional breadth."
TransPerfect Life Sciences has announced that Agility Clinical has implemented Trial Interactive as its electronic Trial Master File (eTMF).
Recipharm has said it will spend SEK5m ($567,000) on a bioanalysis laboratory in Sweden citing the lack of capacity in the Nordic region as a driver for the investment.
BASF is confident the shutdown of its site in Ludwigshafen, Germany will not disrupt the supply of drug excipients.